PharmaLectures.com

Courses › Regulatory affairs by region › United States: Type II Drug Master Files and GDUFA fees, what you file, pay and get

United States: Type II Drug Master Files and GDUFA fees, what you file, pay and get

Your team files Type II Drug Master Files right and pays the right fee first time.

A DMF, or Drug Master File, is a confidential submission to the US Food and Drug Administration that describes how a drug substance or other material is made, so customers can reference it without seeing the details. A Type II DMF covers a drug substance, intermediate, or drug product. The FDA does not approve a DMF on its own; it reviews it when an application references it. Under the Generic Drug User Fee Amendments, a Type II API DMF referenced by a generic application needs a one-time fee and a completeness assessment. Your team gets both in one course.

  • 10 audio modulesthree lengths each
  • 1 h 40 min to 8 h 20 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • RA, QA, BDwho it is written for

Why DMF training matters

A customer's Abbreviated New Drug Application is ready, but the Drug Master File it cites has not had its Generic Drug User Fee Amendments fee paid. The application waits, the launch date slips, and your regulatory team spends the week on the phone and rewriting cover letters.

What changes after this course

Your team builds the file, checks the fee and answers agency letters from a clear routine. You hold a certificate for each learner and a training record per person, ready when an auditor or a customer asks who was trained.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

DMF training: what this course gives your people

Your regulatory affairs team writes the cover letter, the letter of authorization and the administrative section once, and they are right. They work from section 314.420 of Title 21 of the Code of Federal Regulations and the agency's Drug Master Files guidance, so a customer can cite your file without a round of corrections.

Quality assurance checks the process description, specifications, stability data and container closure details against the Module 3 layout of the Common Technical Document before anything leaves the building. Problems surface in your own review, not in a deficiency letter weeks later, and the electronic submission reaches the Electronic Submissions Gateway already checked.

Before signing a supply deal, business development works out whether the file owes a Generic Drug User Fee Amendments fee, which year's published rate applies and when payment falls due. The answer is ready in the meeting, and the customer's Abbreviated New Drug Application is not held up by a fee nobody paid.

When the Food and Drug Administration writes, the team already knows who answers, what goes in the reply and when it is due. Amendments and annual reports go out on schedule, and a change control routine tells you when a file needs updating before a customer finds out first.

Who needs DMF training

  • Regulatory Affairs Specialist

    The agency's validation rejects your electronic Common Technical Document on a Thursday and the customer's filing date is next week. You leave knowing where every document sits and what to check before sending.

  • Quality Assurance Manager

    You are asked to sign off the quality sections of a Drug Master File and doubt the process and stability detail will satisfy a reviewer. You leave with a clear picture of what the reviewer looks for.

  • Business Development Associate

    A customer asks who pays the Drug Master File fee and when. You answer from the Generic Drug User Fee Amendments rules, not from a guess, before the supply agreement is signed.

  • Senior Chemistry, Manufacturing and Controls Scientist

    Regulatory affairs keeps sending your process descriptions back with questions. You leave knowing how to document critical quality attributes and controls the way a reviewer reads them.

Roles: Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: United States

Courses are in English. Other languages on request.

After this course your people can

  1. Draft a cover letter and letter of authorization under section 314.420 of Title 21 of the Code of Federal Regulations that name the right file and customer.
  2. Arrange the quality sections of a Type II file to match Module 3 of the Common Technical Document.
  3. Check an electronic Common Technical Document submission for the faults that cause a technical rejection before you send it.
  4. Decide whether a Type II file owes a Generic Drug User Fee Amendments fee and find the published rate that applies.
  5. Record a fee payment so the agency can link it to the right Drug Master File.
  6. Prepare an annual report that keeps your file active.
  7. Write a point-by-point reply to a deficiency letter or information request and send it before the deadline.

What the company gets

  • Your Type II files reach the agency in a form that passes validation, so customers' filing dates are not tied to your corrections.
  • Your finance team pays the Drug Master File fee at the right time and rate, with a payment record on file.
  • Your customers cite files the agency lists as available for reference, so their Abbreviated New Drug Applications are not held at receipt.
  • Your quality team answers an auditor's question on change control and annual reports with a document, not a recollection.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 10 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 40 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard4 h 10 min25 min a module, for regulatory, quality and business-development staff
Expanded8 h 20 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing1 h 40 min
Regulatory affairsStandard4 h 10 min
Quality assurance and Qualified PersonStandard4 h 10 min

DMF course outline: 10 modules

10 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Decide when a Drug Master File is the right way to submit your data

    • When a customer can cite your file and when they must put their own data in the application.
    • Why a Drug Master File protects your confidential process from the applicant who references it.
    • The Type II scope check that tells you in minutes whether your material belongs in this type.
  2. 2Structure a Type II Drug Master File the way reviewers read it

    • How to order the drug substance sections so a reviewer finds the answer without a phone call.
    • Why mapping your file to Module 3 of the Common Technical Document saves a deficiency round.
    • How to keep confidential process detail protected when a customer cites your file.
  3. 3Draft the cover letter and administrative section that get your file logged

    • What the cover letter must state so the agency logs your submission to the right file and type.
    • The letter of authorization details that let a customer cite your file and the agency find it.
    • What to do when the acknowledgment letter arrives with your assigned Drug Master File number.
  4. 4Write the quality sections so reviewers find the answer on the first read

    • How to present the manufacturing process so the reviewer sees control, not just a flowchart.
    • Why your specifications and stability data decide whether a deficiency letter comes back.
    • The container closure details that reviewers check and holders forget to document.
  5. 5Build an electronic Common Technical Document that passes validation

    • Where each document sits in the electronic Common Technical Document so validation passes.
    • The file formatting faults that cause a technical rejection when the agency validates your submission.
    • What to check before you press send so the completeness assessment starts on time.
  6. 6Apply the Generic Drug User Fee Amendments rules to each of your files

    • Who owes the Drug Master File fee, and the moment in a customer's filing when it falls due.
    • How an unpaid fee on your file can stall a customer's Abbreviated New Drug Application at receipt.
    • When your file is available for reference, and who checks the list before a customer files.
  7. 7Work out the exact user fee for each Drug Master File and pay it correctly

    • How to tell in a few minutes whether your Type II file owes a fee at all.
    • Where to find this year's published fee in the Federal Register and pay the right rate.
    • The payment steps that tie your fee to your file so the agency does not ask for proof later.
  8. 8File amendments and annual reports that keep your file active

    • How to draft an amendment that changes your process without breaking your customers' filings.
    • The annual report content that keeps your file active instead of closed.
    • Why a small administrative slip in a routine update can bring a reviewer back to your whole file.
  9. 9Answer deficiency letters and information requests before the deadline

    • What to do the day a deficiency letter lands, before anyone starts drafting.
    • How to build a response that answers each question in the order the agency asked it.
    • Why a late or partial reply on your file stalls a customer's generic application, not yours alone.
  10. 10Run change control and audits that keep your active files compliant

    • How to set change control triggers that tell you when a file needs an amendment.
    • The signs that a referenced material no longer meets what the agency expects today.
    • What to check in an internal audit of your files before an inspector asks the same question.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about DMF training

What is the GDUFA DMF fee?

Under the Generic Drug User Fee Amendments, the holder of a Type II active pharmaceutical ingredient DMF pays a one-time DMF fee the first time the file is referenced in a generic drug application. After the fee is paid, the FDA carries out a completeness assessment, and a file that passes is listed as available for reference. The fee amount is set again by the FDA for each fiscal year.

Does the FDA approve a Drug Master File?

No. The FDA does not approve or disapprove a DMF on its own. It reviews the technical content only when an application, such as a generic drug application, references the file through a letter of authorisation from the holder. Deficiencies are sent to the DMF holder, who must answer them before the referencing application can move forward. The course walks your team through that cycle.

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

10 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 40 min in the briefing length and 8 h 20 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for RA, QA, BD. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 90 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team